Skip to content
Lower risk Medical device recall · FDA · Published July 30, 2024

Siemens Dimension Vista TBIL Reagent Cartridge Recall: Underfill Risk

Siemens recalls Dimension Vista TBIL Flex Reagent Cartridges with lot 23206BA due to potential underfilling during manufacturing, which may affect calibrator and patient results.

🇺🇸 FDA recall #Z-3065-2024Medical deviceSiemens Healthcare ›
Take action

Contact the company

Recalling firmSiemens Healthcare Diagnostics, Inc.500 Gbc Dr · Newark, DE 19702-2466
✎ GovInfoNow plain-language explainer

Siemens is recalling Dimension Vista Total Bilirubin (TBIL) Flex Reagent Cartridges with lot number 23206BA because some cartridges may underfill during manufacturing. This could lead to inaccurate calibrator or patient test results if used. Read more at govinfonow.com/recall/54381-siemens-dimension-vista-tbil-reagent-cartridge-recall-underfill-risk.

Source Summary by GovInfoNow · govinfonow.com/recall/54381-siemens-dimension-vista-tbil-reagent-cartridge-recall-underfill-risk · Updated August 19, 2026 · FDA enforcement record: FDA #Z-3065-2024

Cite this page

“Siemens Dimension Vista TBIL Reagent Cartridge Recall: Underfill Risk.” GovInfoNow, updated August 19, 2026. https://govinfonow.com/recall/54381-siemens-dimension-vista-tbil-reagent-cartridge-recall-underfill-risk. Based on FDA recall #Z-3065-2024 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-3065-2024%22&limit=1).

The FDA announced on July 30, 2024, that Siemens Healthcare Diagnostics, Inc. is recalling Dimension Vista Total Bilirubin (TBIL) Flex Reagent Cartridges due to potential underfilling during manufacturing. This defect could impact calibrator, quality control, and patient results.

How to tell if you have it

  • Brand: Siemens Healthcare
  • Product: Dimension Vista Total Bilirubin (TBIL) Flex Reagent Cartridge
  • Siemens Material Number (SMN): 10445146
  • UDI-DI: 00842768015717
  • Lot Number: 23206BA

The hazard

During manufacturing, an issue with the filling line caused some wells in lot 23206BA to underfill. This defect may have impacted calibrator, quality control (QC), and patient results.

Context

GovInfoNow's records show Siemens Healthcare Diagnostics, Inc. has 150 other recalls on record since June 7, 2017. Other recent recalls include the Siemens Atellica CH RCRP Test recall (Aug. 17, 2026) and the Siemens Atellica CH Urine Albumin Recall (July 6, 2026). Similar product recalls include the Milestone Vacuum Bag SU Large Specimen Container Recall (March 9, 2026) and the Henry Schein Structur 2 SC Resin Cartridge Refills recall (July 9, 2026).

How to tell if you have this one

Check for lot number 23206BA on the Siemens Dimension Vista TBIL Flex Reagent Cartridge. The product has Siemens Material Number (SMN) 10445146 and UDI-DI 00842768015717.

  • Brand
    Siemens Healthcare
  • Category
    Medical device
Based on the official FDA remedy

What to do — step by step

  1. Check Lot Number

    Look for lot number 23206BA on the reagent cartridge packaging.

Where it went and when

Where it was distributed

Distributed nationwide, and outside the U.S.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Domestic: Nationwide Distribution. International: Austria, Belgium, Canada, Czech Republic, Denmark, France, Germany, Italy, Qatar, Slovenia, Spain, Switzerland.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide, and outside the U.S.

Recall timeline

FDA published this recall 50 days after the firm started it.

1. Firm started the recall: Jul 30, 202412. FDA classified it Class II: Sep 6, 202423. Published in FDA’s Enforcement Report: Sep 18, 202432024
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest medical device recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #Z-3065-2024 (July 30, 2024) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-3065-2024 to see it in context.
  • Plain-language summary written by qwen3:4b on August 19, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA